您的位置:山东大学 -> 科技期刊社 -> 《山东大学学报(医学版)》

山东大学学报(医学版) ›› 2014, Vol. 52 ›› Issue (7): 11-15.doi: 10.6040/j.issn.1671-7554.0.2014.010

• 基础医学 • 上一篇    下一篇

多奈哌齐对阿尔茨海默病模型大鼠下丘脑-垂体-肾上腺轴的影响

王金红1, 李文涛2, 于树田1, 董丽1   

  1. 1. 潍坊医学院 药理学教研室, 山东 潍坊 261053;
    2. 潍坊医学院 机能学实验室, 山东 潍坊 261053
  • 收稿日期:2014-01-06 修回日期:2014-06-10 出版日期:2014-07-10 发布日期:2014-07-10
  • 通讯作者: 王金红。E-mail:wfmcwjh@wfmc.edu.cn E-mail:wfmcwjh@wfmc.edu.cn
  • 基金资助:
    山东省高等学校科技计划项目(J09LF81);山东省优秀中青年科学家科研奖励基金(BS2010YY072);山东省自然科学基金(ZR2010DM010;ZR2013HL069)

Effect of donepezil on hypothalamic-pituitary-adrenocortical-axis in Alzheimer’s disease rats

WANG Jinhong1, LI Wentao2, YU Shutian1, DONG Li1   

  1. 1. Department of Pharmacology, Weifang Medical University, Weifang 261053, Shandong, China;
    2. Department of Functional Laboratory, Weifang Medical University, Weifang 261053, Shandong, China
  • Received:2014-01-06 Revised:2014-06-10 Online:2014-07-10 Published:2014-07-10

摘要: 目的 探讨多奈哌齐对阿尔茨海默病(AD)模型大鼠下丘脑-垂体-肾上腺轴(HPA)的影响。方法 健康雄性Wistar大鼠侧脑室注射β-淀粉样蛋白(25-35) (Aβ25-35)和腹腔注射D-半乳糖(D-gal)结合制备AD模型,随机分为正常对照组、模型对照组、多奈哌齐组,每组10只。放射免疫测定大鼠HPA相关激素可的松(HYD)、促肾上腺皮质激素(ACTH)含量,免疫组织化学法观察下丘脑促肾上腺皮质激素释放激素(CRH)及相关受体亚型1(CRH-R1)的表达,电镜观察下丘脑超微结构。结果 与正常对照组大鼠相比,模型对照组大鼠的学习能力明显减退(P<0.05),血清HYD明显升高(P<0.01),ACTH水平显著降低(P<0.01),下丘脑CRH和CRHR1表达减少,阳性染色神经元数目减少,超微结构呈损伤性改变。与模型对照组相比,多奈哌齐组大鼠血清HYD降低,ACTH逐渐升高(P<0.05或P<0.01),CRH和CRHR1表达增加,下丘脑超微结构损伤改善。结论 多奈哌齐能够改善AD大鼠HPA功能,对AD具有治疗作用。

关键词: 多奈哌齐, 促肾上腺皮质激素释放激素, 阿尔茨海默病模型大鼠, 促肾上腺皮质激素, 可的松

Abstract: Objective To investigate the effect of donepezil on hypothalamic-pituitary-adrenocortical-axis(HPA)in Alzheimer's disease (AD) rats. Methods A total of 30 healthy male Wistar rats were injected into amyloid β-protein 25-35 (Aβ25-35) intracerebroventricularly and D-galactose (D-gal) intraperitoneally to prepare AD model and divided into normal control group, AD model group, and donepezil group randomly, and 10 rats in each group. Serum hydrocortisone (HYD) and adrenocorticotropic hormone (ACTH) concentrations were detected by radioimmunoassay. Morphology of hypothalamus was observed with transmission electron microscope, and the expressions of corticotropin releasing hormone (CRH) and CRH receptor 1 (CRHR1) were observed by immunohistochemical method. Results Compared with normal control group, learning ability of model rats decreased (P<0.05), HYD concentration increased (P<0.01), ACTH concentration decreased significantly (P<0.01), and the expressions of CRH and CRHR1 reduced. The ultrastructure of hypothalamus of model rats were damaged. Compared with AD model group, donepezil decreased serum concentration of HYD and increased serum concentration of ACTH in the AD rats (P<0.05 or P<0.01 respectively), and improved the expressions of CRH and CRHR1, which protected ultrastructure damage of hypothalamus. Conclusion Donepezil improves the function of HPA in AD rats and shows treatment effect on AD.

Key words: Donepezil, Adrenocorticotropic hormone, Alzheimer’s disease rats, Corticotropin releasing hormone, Hydrocortisone

中图分类号: 

  • R574
[1] Cutuli D, De Bartolo P, Caporali P, et al. Neuroprotective effects of donepezil against cholinergic depletion[J]. Alzheimers Res Ther, 2013, 5(5): 50. doi: 10.1186/alzrt215.
[2] Thakurathi N, Vincenzi B, Henderson D C. Assessing the prospect of donepezil in improving cognitive impairment in patients with schizophrenia[J]. Expert Opin Investig Drugs, 2013, 22(2): 259-265.
[3] Zivin M, Pregelj P. Prolonged treatment with donepezil increases acetylcholinesterase expression in the central nervous system[J]. Psychiatr Danub, 2008, 20(2): 168-173.
[4] Umegaki H, Yamamoto A, Suzuki Y, et al. Responses of hypothalamo-pituitary-adrenal axis to a cholinesterase inhibitor[J]. Neuroreport, 2009, 20 (15): 1366-1370.
[5] Notarianni E. Hypercortisolemia and glucocorticoid receptor-signaling insufficiency in Alzheimer's disease initiation and development[J]. Curr Alzheimer Res, 2013, 10(7): 714-731.
[6] Brureau A, Zussy C, Delair B, et al. Deregulation of hypothalamic-pituitary-adrenal axis functions in an Alzheimer's disease rat model[J]. Neurobiol Aging, 2013, 34(5): 1426-1439.
[7] Xue H Y, Lu Y N, Fang X M, et al. Neuroprotective properties of aucubin in diabetic rats and diabetic encephalopathy rats[J]. Mol Biol Rep, 2012, 39(10): 9311-9318.
[8] 汪润,赵丽娟,王全英,等.β淀粉样蛋白1-42与D-半乳糖联合作用建立复合阿尔茨海默病样模型[J]. 解剖学报, 2011, 42(4): 342-343.
[9] 包新民, 舒斯云. 大鼠脑立体定位图谱[M].2版.北京:人民卫生出版社, 2005: 165.
[10] Mehta S, Chandersekhar K, Prasadrao G, et al. Safety and efficacy of donepezil hydrochloride in patients with mild to moderate Alzheimer's disease: findings of an observational study[J]. Indian J Psychiatry, 2012, 54(4): 337-343.
[11] Sozio P, Cerasa L S, Marinelli L, et al. Transdermal donepezil on the treatment of Alzheimer's disease[J]. Neuropsychiatr Dis Treat, 2012, 8: 361-368. doi: 10.2147/NDT.S16089.
[12] 周智林,梁丽贞,严永兴. 多奈哌齐对阿尔茨海默病患者甲状腺功能的影响研究[J]. 中国老年保健医学, 2006, 4(2): 23-24.
[13] 高旭红,赵海花,赖红,等. 多奈哌齐对AD大鼠海马结构神经元的保护作用[J].中国组织化学与细胞化学杂志, 2012, 21(1): 33-36.
[14] De Souza E B, Whitehouse P J, Kuhar M J, et al. Reciprocal changes in corticotrophin-releasing factor(CRF)-like immunoreactivity and CRH receptors in cerebral cortex of Alzheimer's disease[J]. Nature, 1986, 319(6054): 593-595.
[15] Carroll J C, Iba M, Bangasser D A, et al. Chronic stress exacerbates tau pathology, neurodegeneration, and cognitive performance through a corticotropin-releasing factor receptor-dependent mechanism in a transgenic mouse model of tauopathy[J]. J Neurosci, 2011, 31(40): 14436-14449.
[1] 李霞,李理想,李铭,陈飞雪,左秀丽,李延青. 促肾上腺皮质激素释放因子对肠道杯状细胞分泌产物的影响[J]. 山东大学学报(医学版), 2017, 55(4): 44-49.
[2] 龙欣欣,王学禹. 小剂量促皮质素治疗婴儿痉挛的临床疗效及随访分析[J]. 山东大学学报(医学版), 2012, 50(5): 88-91.
[3] 朱艳利1,王秀莉2,朱学梅1,卓晶明1,李文华1. 高血压患者晨间血压升高的病因探讨[J]. 山东大学学报(医学版), 2011, 49(7): 113-116.
[4] 于海丽,王学禹,席加水,孙文秀. 两种剂量ACTH治疗婴儿痉挛的疗效及不良反应对比分析[J]. 山东大学学报(医学版), 2010, 48(2): 100-104.
[5] 刘欣,杨乐金,樊淑娟,江虹,潘芳. 有氧运动对急应激暴露下CUMS大鼠的保护作用
[J]. 山东大学学报(医学版), 2009, 47(02): 88-91.
[6] 江虹,张茜,孙钰,潘芳 . 医科新生状态-特质焦虑与人格、应对方式及唾液皮质醇的相关性[J]. 山东大学学报(医学版), 2008, 46(9): 866-868.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!